BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 27912762)

  • 1. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
    Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
    J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity.
    Yang Y; Winger RC; Lee PW; Nuro-Gyina PK; Minc A; Larson M; Liu Y; Pei W; Rieser E; Racke MK; Lovett-Racke AE
    Clin Exp Immunol; 2015 Jan; 179(1):108-18. PubMed ID: 25142403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity.
    Kraus EE; Kakuk-Atkins L; Farinas MF; Jeffers M; Lovett-Racke AE; Yang Y
    J Neuroimmunol; 2021 Oct; 359():577675. PubMed ID: 34403862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis.
    Skundric DS; Cruikshank WW; Drulovic J
    J Neuroinflammation; 2015 Apr; 12():78. PubMed ID: 25896927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
    Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
    Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
    J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis.
    Sandy AR; Stoolman J; Malott K; Pongtornpipat P; Segal BM; Maillard I
    J Immunol; 2013 Aug; 191(4):1606-13. PubMed ID: 23825310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
    Zilkha-Falb R; Kaushansky N; Kawakami N; Ben-Nun A
    J Neuroinflammation; 2016 Jan; 13():7. PubMed ID: 26747276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes T
    Aqel SI; Kraus EE; Jena N; Kumari V; Granitto MC; Mao L; Farinas MF; Zhao EY; Perottino G; Pei W; Lovett-Racke AE; Racke MK; Fuchs JR; Li C; Yang Y
    Clin Exp Immunol; 2019 May; 196(2):215-225. PubMed ID: 30615197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.
    Holz K; Prinz M; Brendecke SM; Hölscher A; Deng F; Mitrücker HW; Rose-John S; Hölscher C
    Front Immunol; 2018; 9():836. PubMed ID: 29770132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.